Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation

Paulus Kirchhof*, Karl Georg Haeusler, Benjamin Blank, Joseph De Bono, David Callans, Arif Elvan, Thomas Fetsch, Isabelle C. Van Gelder, Philip Gentlesk, Massimo Grimaldi, Jim Hansen, Gerhard Hindricks, Hussein R. Al-Khalidi, Tyler Massaro, Lluis Mont, Jens Cosedis Nielsen, Georg Nolker, Jonathan P. Piccini, Tom De Potter, Daniel ScherrUlrich Schotten, Sakis Themistoclakis, Derick Todd, Johan Vijgen, Luigi Di Biase

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2942-2955
Number of pages14
JournalEuropean Heart Journal
Volume39
Issue number32
DOIs
Publication statusPublished - 21 Aug 2018

Keywords

  • Atrial fibrillation
  • Ablation
  • Anticoagulation
  • Bleeding
  • Stroke
  • Brain MRI
  • HEART RHYTHM ASSOCIATION
  • VITAMIN-K ANTAGONISTS
  • CATHETER ABLATION
  • ANTICOAGULATION MANAGEMENT
  • RADIOFREQUENCY ABLATION
  • TRIAL
  • CRYOBALLOON
  • WARFARIN
  • THERAPY
  • LESIONS

Cite this